发明名称 |
SYNERGIC COMBINATIONS COMPRISING A STYRYLQUINOLINE COMPOUND AND OTHER HIV INFECTION THERAPEUTIC AGENTS |
摘要 |
The invention relates to a combination comprising a quinoline compound or its salt, according to general formula (I) and at least one HIV infection therapeutic agent selected from the group consisting of entry inhibitors, reverse-transcriptase inhibitors, strand-transfer inhibitors, protease inhibitors, and maturation inhibitors. Said combination has therapeutic synergy in the treatment of an HIV infection compared with the quinoline compound, or HIV infection therapeutic agent alone.
|
申请公布号 |
CA2610029(A1) |
申请公布日期 |
2006.12.07 |
申请号 |
CA20052610029 |
申请日期 |
2005.06.01 |
申请人 |
BIOALLIANCE PHARMA;UNIVERSITE DE PARIS 11-PARIS SUD;C.N.R.S.;ECOLE NATIONALE SUPERIEURE DE CACHAN |
发明人 |
THOMAS, CLAIRE-MARIE;MOUSCADET, JEAN-FRANCOIS;ZOUHIRI, FATIMA;LEH, HERVE;COSTANTINI, DOMINIQUE;DAM, ELISABETH |
分类号 |
A61K31/47;A61K31/402;A61K31/506;A61K31/551;A61P31/18;C07D215/48 |
主分类号 |
A61K31/47 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|